A large scale multicentre randomized, placebo-controlled subcutaneous house dust mite allergen immunotherapy (HDM SCIT) in allergic rhinitis: MITAR Study

Previous house dust mite subcutaneous immunotherapy (HDM SCIT) placebo-controlled trials have small sample sizes and lack a consensus on baseline treatment. To determine the efficacy of HDM SCIT in moderate-to-severe allergic rhinitis (AR) patients treated with an intranasal corticosteroid at baseli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Asian Pacific journal of allergy and immunology 2024-09, Vol.42 (3), p.233-245
Hauptverfasser:	Suratannon, Narissara, Limsuwan, Ticha, Tantilipikorn, Pongsakorn, Chatchatee, Pantipa, Saengapaswiriya, Atik, Boonpiyathad, Tadech, Thongngarm, Torpong, Roongpuvapaht, Boonsam, Chantaphakul, Hiroshi, Kulalert, Prapasri, Thanaviratananich, Sanguansak, Sangsupawanich, Pasuree, Fooanant, Supranee, Manuyakorn, Wiparat, Chusakul, Supinda, Piboonpochanun, Orathai, Apornpong, Tanakorn, Wongpiyabovorn, Jongkonnee, Ruxrungtham, Kiat
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Allergens - immunology Allergic rhinitis Animals Antigens, Dermatophagoides - immunology Child Clinical trials Dermatophagoides pteronyssinus - immunology Desensitization, Immunologic - methods Female Hay fever Humans Immunoglobulin G4 Immunotherapy Injections, Subcutaneous Male Medical treatment Middle Aged Placebos Pyroglyphidae - immunology Rhinitis Rhinitis, Allergic - immunology Rhinitis, Allergic - therapy Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!